AFfirm™ Ezrin Mouse Monoclonal Antibody - #BF8182
Product Info
*The optimal dilutions should be determined by the end user.
*Tips:
WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.
Fold/Unfold
Villin 2 ezrin; CVIL; CVL; Cytovillin 2; Cytovillin; DKFZp762H157; Epididymis secretory protein Li 105; EZR; EZRI_HUMAN; Ezrin; FLJ26216; HEL S 105; MGC1584; p81; VIL 2; VIL2; Villin 2 (ezrin); Villin 2; Villin-2; Villin2;
Immunogens
A synthesized peptide derived from human Ezrin around the site of Tyr478.
Expressed in cerebral cortex, basal ganglia, hippocampus, hypophysis, and optic nerve. Weakly expressed in brain stem and diencephalon. Stronger expression was detected in gray matter of frontal lobe compared to white matter (at protein level). Component of the microvilli of intestinal epithelial cells. Preferentially expressed in astrocytes of hippocampus, frontal cortex, thalamus, parahippocampal cortex, amygdala, insula, and corpus callosum. Not detected in neurons in most tissues studied.
- P15311 EZRI_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MPKPINVRVTTMDAELEFAIQPNTTGKQLFDQVVKTIGLREVWYFGLHYVDNKGFPTWLKLDKKVSAQEVRKENPLQFKFRAKFYPEDVAEELIQDITQKLFFLQVKEGILSDEIYCPPETAVLLGSYAVQAKFGDYNKEVHKSGYLSSERLIPQRVMDQHKLTRDQWEDRIQVWHAEHRGMLKDNAMLEYLKIAQDLEMYGINYFEIKNKKGTDLWLGVDALGLNIYEKDDKLTPKIGFPWSEIRNISFNDKKFVIKPIDKKAPDFVFYAPRLRINKRILQLCMGNHELYMRRRKPDTIEVQQMKAQAREEKHQKQLERQQLETEKKRRETVEREKEQMMREKEELMLRLQDYEEKTKKAERELSEQIQRALQLEEERKRAQEEAERLEADRMAALRAKEELERQAVDQIKSQEQLAAELAEYTAKIALLEEARRRKEDEVEEWQHRAKEAQDDLVKTKEELHLVMTAPPPPPPPVYEPVSYHVQESLQDEGAEPTGYSAELSSEGIRDDRNEEKRITEAEKNERVQRQLLTLSSELSQARDENKRTHNDIIHNENMRQGRDKYKTLRQIRQGNTKQRIDEFEAL
PTMs - P15311 As Substrate
Site | PTM Type | Enzyme | Source |
---|---|---|---|
K3 | Ubiquitination | Uniprot | |
K35 | Acetylation | Uniprot | |
K35 | Ubiquitination | Uniprot | |
T57 | Phosphorylation | Uniprot | |
K60 | Acetylation | Uniprot | |
K64 | Ubiquitination | Uniprot | |
S66 | Phosphorylation | P17612 (PRKACA) | Uniprot |
K72 | Ubiquitination | Uniprot | |
K79 | Acetylation | Uniprot | |
K79 | Ubiquitination | Uniprot | |
K83 | Ubiquitination | Uniprot | |
K107 | Ubiquitination | Uniprot | |
S112 | Phosphorylation | Uniprot | |
Y116 | Phosphorylation | Uniprot | |
Y137 | Phosphorylation | Uniprot | |
K139 | Acetylation | Uniprot | |
K139 | Ubiquitination | Uniprot | |
K143 | Ubiquitination | Uniprot | |
S144 | Phosphorylation | Uniprot | |
Y146 | Phosphorylation | P00533 (EGFR) , P16591 (FER) , P12931 (SRC) , P06239 (LCK) | Uniprot |
S149 | Phosphorylation | Uniprot | |
K162 | Ubiquitination | Uniprot | |
R171 | Methylation | Uniprot | |
K184 | Acetylation | Uniprot | |
K184 | Ubiquitination | Uniprot | |
Y191 | Phosphorylation | Uniprot | |
Y201 | Phosphorylation | Uniprot | |
Y205 | Phosphorylation | Uniprot | |
K209 | Ubiquitination | Uniprot | |
K211 | Ubiquitination | Uniprot | |
K230 | Sumoylation | Uniprot | |
K230 | Ubiquitination | Uniprot | |
K233 | Sumoylation | Uniprot | |
K233 | Ubiquitination | Uniprot | |
T235 | Phosphorylation | Q00535 (CDK5) | Uniprot |
K237 | Ubiquitination | Uniprot | |
S243 | Phosphorylation | Uniprot | |
S249 | Phosphorylation | Uniprot | |
K253 | Acetylation | Uniprot | |
K253 | Ubiquitination | Uniprot | |
K254 | Ubiquitination | Uniprot | |
K258 | Acetylation | Uniprot | |
K258 | Ubiquitination | Uniprot | |
K262 | Acetylation | Uniprot | |
K262 | Sumoylation | Uniprot | |
K262 | Ubiquitination | Uniprot | |
K263 | Acetylation | Uniprot | |
K263 | Ubiquitination | Uniprot | |
Y270 | Phosphorylation | Uniprot | |
R273 | Methylation | Uniprot | |
Y291 | Phosphorylation | Uniprot | |
K296 | Ubiquitination | Uniprot | |
T299 | Phosphorylation | Uniprot | |
K306 | Methylation | Uniprot | |
K306 | Ubiquitination | Uniprot | |
T332 | Phosphorylation | Uniprot | |
K337 | Ubiquitination | Uniprot | |
K344 | Ubiquitination | Uniprot | |
Y354 | Phosphorylation | P16591 (FER) , P00533 (EGFR) | Uniprot |
K357 | Sumoylation | Uniprot | |
K357 | Ubiquitination | Uniprot | |
S366 | Phosphorylation | Uniprot | |
R393 | Methylation | Uniprot | |
K412 | Acetylation | Uniprot | |
K412 | Ubiquitination | Uniprot | |
S413 | Phosphorylation | Uniprot | |
Y424 | Phosphorylation | Uniprot | |
T425 | Phosphorylation | Uniprot | |
K427 | Ubiquitination | Uniprot | |
R435 | Methylation | Uniprot | |
K438 | Ubiquitination | Uniprot | |
K450 | Ubiquitination | Uniprot | |
K458 | Ubiquitination | Uniprot | |
T468 | Phosphorylation | Uniprot | |
Y478 | Phosphorylation | P12931 (SRC) , P16591 (FER) | Uniprot |
S482 | Phosphorylation | Uniprot | |
Y483 | Phosphorylation | Uniprot | |
S488 | Phosphorylation | Uniprot | |
T497 | Phosphorylation | Uniprot | |
Y499 | Phosphorylation | Uniprot | |
K523 | Ubiquitination | Uniprot | |
S535 | Phosphorylation | Uniprot | |
S536 | Phosphorylation | Uniprot | |
S539 | Phosphorylation | Uniprot | |
T548 | Phosphorylation | Uniprot | |
Y565 | Phosphorylation | Uniprot | |
T567 | Phosphorylation | P17252 (PRKCA) , Q5S007 (LRRK2) , P41279 (MAP3K8) , O94804 (STK10) , O95819 (MAP4K4) , P25098 (GRK2) , P31751 (AKT2) , Q13464 (ROCK1) , Q04759 (PRKCQ) , Q9P289 (STK26) , P41743 (PRKCI) , O75116 (ROCK2) | Uniprot |
T576 | Phosphorylation | Uniprot |
Research Backgrounds
Probably involved in connections of major cytoskeletal structures to the plasma membrane. In epithelial cells, required for the formation of microvilli and membrane ruffles on the apical pole. Along with PLEKHG6, required for normal macropinocytosis.
Phosphorylated by tyrosine-protein kinases. Phosphorylation by ROCK2 suppresses the head-to-tail association of the N-terminal and C-terminal halves resulting in an opened conformation which is capable of actin and membrane-binding (By similarity).
S-nitrosylation is induced by interferon-gamma and oxidatively-modified low-densitity lipoprotein (LDL(ox)) possibly implicating the iNOS-S100A8/9 transnitrosylase complex.
Apical cell membrane>Peripheral membrane protein>Cytoplasmic side. Cell projection. Cell projection>Microvillus membrane>Peripheral membrane protein>Cytoplasmic side. Cell projection>Ruffle membrane>Peripheral membrane protein>Cytoplasmic side. Cytoplasm>Cell cortex. Cytoplasm>Cytoskeleton. Cell projection>Microvillus.
Note: Localization to the apical membrane of parietal cells depends on the interaction with MPP5. Localizes to cell extensions and peripheral processes of astrocytes (By similarity). Microvillar peripheral membrane protein (cytoplasmic side).
Expressed in cerebral cortex, basal ganglia, hippocampus, hypophysis, and optic nerve. Weakly expressed in brain stem and diencephalon. Stronger expression was detected in gray matter of frontal lobe compared to white matter (at protein level). Component of the microvilli of intestinal epithelial cells. Preferentially expressed in astrocytes of hippocampus, frontal cortex, thalamus, parahippocampal cortex, amygdala, insula, and corpus callosum. Not detected in neurons in most tissues studied.
Interacts with MPP5 and SLC9A3R2. Found in a complex with EZR, PODXL and SLC9A3R2 (By similarity). Interacts with MCC, PLEKHG6, PODXL, SCYL3/PACE1, SLC9A3R1 and TMEM8B. Interacts (when phosphorylated) with FES/FPS. Interacts with dimeric S100P, the interaction may be activating through unmasking of F-actin binding sites. Identified in complexes that contain VIM, EZR, AHNAK, BFSP1, BFSP2, ANK2, PLEC, PRX and spectrin (By similarity). Detected in a complex composed of at least EZR, AHNAK, PPL and PRX (By similarity). Interacts with PDPN (via cytoplasmic domain); activates RHOA and promotes epithelial-mesenchymal transition. Interacts with SPN, CD44 and ICAM2 (By similarity).
The [IL]-x-C-x-x-[DE] motif is a proposed target motif for cysteine S-nitrosylation mediated by the iNOS-S100A8/A9 transnitrosylase complex.
Research Fields
· Cellular Processes > Cellular community - eukaryotes > Tight junction. (View pathway)
· Cellular Processes > Cell motility > Regulation of actin cytoskeleton. (View pathway)
· Human Diseases > Infectious diseases: Bacterial > Pathogenic Escherichia coli infection.
· Human Diseases > Cancers: Overview > Proteoglycans in cancer.
· Human Diseases > Cancers: Overview > MicroRNAs in cancer.
· Organismal Systems > Immune system > Leukocyte transendothelial migration. (View pathway)
· Organismal Systems > Digestive system > Gastric acid secretion.
Restrictive clause
Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.
For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.